Commerce Bank’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$533K Buy
24,494
+161
+0.7% +$3.12K ﹤0.01% 914
2025
Q4
$524K Buy
24,333
+1,412
+6% +$29.8K ﹤0.01% 861
2025
Q3
$442K Buy
+22,921
New +$409K ﹤0.01% 921
2025
Q1
Sell
-2,041
Closed -$248K 1198
2024
Q4
$248K Buy
2,041
+25
+1% +$3.06K ﹤0.01% 1085
2024
Q3
$252K Buy
2,016
+274
+16% +$37.9K ﹤0.01% 1112
2024
Q2
$275K Buy
1,742
+57
+3% +$7.32K ﹤0.01% 1052
2024
Q1
$218K Buy
+1,685
New +$206K ﹤0.01% 1124
2023
Q4
Sell
-1,943
Closed -$236K 1202
2023
Q3
$236K Buy
1,943
+143
+8% +$16.2K ﹤0.01% 1040
2023
Q2
$206K Buy
1,800
+236
+15% +$30.4K ﹤0.01% 1084
2023
Q1
$216K Buy
+1,564
New +$203K ﹤0.01% 1079
2022
Q2
Sell
-2,693
Closed -$210K 1202
2022
Q1
$210K Buy
2,693
+361
+15% +$27.6K ﹤0.01% 1124
2021
Q4
$210K Buy
+2,332
New +$199K ﹤0.01% 1134
2021
Q3
Sell
-3,499
Closed -$272K 1183
2021
Q2
$272K Buy
3,499
+242
+7% +$18.3K ﹤0.01% 1037
2021
Q1
$243K Buy
3,257
+230
+8% +$21.2K ﹤0.01% 1045
2020
Q4
$516K Sell
3,027
-164
-5% -$24.3K ﹤0.01% 762
2020
Q3
$448K Buy
3,191
+7
+0.2% +$1.06K ﹤0.01% 719
2020
Q2
$511K Sell
3,184
-48
-1% -$6.53K 0.01% 660
2020
Q1
$316K Buy
+3,232
New +$369K ﹤0.01% 744

Other funds holding SRPT

Commerce Bank's SRPT Position: Q1 2026 in Review

Commerce Bank increased its Sarepta Therapeutics (SRPT) stake by 0.66% in Q1 2026, buying an estimated $3.12K and bringing the position to 24,494 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Commerce Bank first reported a position in SRPT in Q1 2020 and has held it in 18 quarters since. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Commerce Bank held 24,494 shares of Sarepta Therapeutics worth $533K as of Q1 2026.
  • Commerce Bank bought 161 Sarepta Therapeutics shares in Q1 2026, an estimated $3.12K.
  • Sarepta Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #914 holding.
  • Commerce Bank first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.